# Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)

> **NCT06204237** · EARLY_PHASE1 · RECRUITING · sponsor: **Aplagon Oy** · enrollment: 10 (estimated)

## Conditions studied

- Peripheral Arterial Occlusive Disease
- Critical Limb Ischemia

## Interventions

- **DRUG:** [89Zr]Zr-DFO-APAC
- **RADIATION:** PET/CT scan

## Key facts

- **NCT ID:** NCT06204237
- **Lead sponsor:** Aplagon Oy
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-01
- **Primary completion:** 2025-06
- **Final completion:** 2025-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06204237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06204237, "Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06204237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*